Dennis Akkaya

Chief Commercial Officer myTomorrows

Seminars

Monday 19th October 2026
Workshop G: The EAP Flywheel: Sequencing Expanded Access from Trial Design to Commercial Launch
3:00 pm
  • Learning how to position Expanded Access as a cross-functional capability across Medical, Clinical, and Commercial teams, supported by governance models that enable launch readiness while remaining compliant and patient-centric
  • Exploring how patient experience and outcomes from Expanded Access can generate longitudinal insights that inform regulatory, medical, and market-access decisions across jurisdictions
  • Learning a framework for determining where and when to establish Expanded Access, balancing country prioritization, patient continuity, launch sequencing, and regulatory considerations
  • Discovering how EAP insights, including patient outcomes, site experience, and operational learnings, can support Medical Affairs, Market Access, HEOR, and launch planning objectives

Monday 19th October 2026
Workshop G: The EAP Flywheel: Sequencing Expanded Access from Trial Design to Commercial Launch
3:00 pm
  • Learning how to position Expanded Access as a cross-functional capability across Medical, Clinical, and Commercial teams, supported by governance models that enable launch readiness while remaining compliant and patient-centric
  • Exploring how patient experience and outcomes from Expanded Access can generate longitudinal insights that inform regulatory, medical, and market-access decisions across jurisdictions
  • Learning a framework for determining where and when to establish Expanded Access, balancing country prioritization, patient continuity, launch sequencing, and regulatory considerations
  • Discovering how EAP insights, including patient outcomes, site experience, and operational learnings, can support Medical Affairs, Market Access, HEOR, and launch planning objectives
Tuesday 20th October 2026
Chair’s Opening Remarks
8:25 am
Tuesday 20th October 2026
Chair’s Closing Remarks
5:30 pm
Dennis Akkaya - 5th Operationalise Early Access Programmes Europe